Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yutian Feng

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Nuclear Medicine and Biology|June 18, 2021
Production, purification and availability of <sup>211</sup>At: Near term steps towards global accessYutian Feng, Michael R Zalutsky
Systematic Biology|July 21, 2021
Improving Phylogenies Based on Average Nucleotide Identity, Incorporating Saturation Correction and Nonparametric Bootstrap SupportSean Gosselin, Matthew S Fullmer, Yutian Feng, et al.
Nuclear Medicine and Biology|May 20, 2025
Enhancing the therapeutic index of [<sup>211</sup>At]YF2 with iodo pseudo carrier: A simple strategy for reducing accumulation in kidneys, salivary and lacrimal glandsTruc T Huynh, Yutian Feng, Rebecca L Banks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 26, 2022
Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose <sup>211</sup>At-Labeled Anti-HER2 Single-Domain Antibody FragmentYutian Feng, Rebecca Meshaw, Xiao-Guang Zhao, et al.
Nuclear Medicine and Biology|May 26, 2020
Site-specific radioiodination of an anti-HER2 single domain antibody fragment with a residualizing prosthetic agentYutian Feng, Zhengyuan Zhou, Darryl McDougald, et al.
Scientific Reports|October 10, 2025
Comprehensive analysis of reservoir comparison and controls on pore structure in the Wufeng-Longmaxi shale, Southern SichuanYijiang Leng, Hongming Tang, Yutian Feng, et al.
Iliver|October 7, 2025
Nucleic acid therapeutics for liver diseases: A decade of technological convergence and clinical challengesYufei Pan, Mingyue Pan, Yuanzheng Huang, et al.
ILIVER|July 10, 2025
Innovations in 3D bioprinting and biomaterials for liver tissue engineering: Paving the way for tissue-engineered liverQi Wang, Yutian Feng, Anqi Wang, et al.
Nuclear Medicine and Biology|May 7, 2016
Trithiols and their arsenic compounds for potential use in diagnostic and therapeutic radiopharmaceuticalsAnthony J DeGraffenreid, Yutian Feng, Charles L Barnes, et al.
Genome Biology and Evolution|July 13, 2021
The Evolutionary Origins of Extreme Halophilic Archaeal LineagesYutian Feng, Uri Neri, Sean Gosselin, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Nuclear Medicine and Biology|June 18, 2021
Production, purification and availability of <sup>211</sup>At: Near term steps towards global accessYutian Feng, Michael R Zalutsky
Systematic Biology|July 21, 2021
Improving Phylogenies Based on Average Nucleotide Identity, Incorporating Saturation Correction and Nonparametric Bootstrap SupportSean Gosselin, Matthew S Fullmer, Yutian Feng, et al.
Nuclear Medicine and Biology|May 20, 2025
Enhancing the therapeutic index of [<sup>211</sup>At]YF2 with iodo pseudo carrier: A simple strategy for reducing accumulation in kidneys, salivary and lacrimal glandsTruc T Huynh, Yutian Feng, Rebecca L Banks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 26, 2022
Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose <sup>211</sup>At-Labeled Anti-HER2 Single-Domain Antibody FragmentYutian Feng, Rebecca Meshaw, Xiao-Guang Zhao, et al.
Nuclear Medicine and Biology|May 26, 2020
Site-specific radioiodination of an anti-HER2 single domain antibody fragment with a residualizing prosthetic agentYutian Feng, Zhengyuan Zhou, Darryl McDougald, et al.
Scientific Reports|October 10, 2025
Comprehensive analysis of reservoir comparison and controls on pore structure in the Wufeng-Longmaxi shale, Southern SichuanYijiang Leng, Hongming Tang, Yutian Feng, et al.
Iliver|October 7, 2025
Nucleic acid therapeutics for liver diseases: A decade of technological convergence and clinical challengesYufei Pan, Mingyue Pan, Yuanzheng Huang, et al.
ILIVER|July 10, 2025
Innovations in 3D bioprinting and biomaterials for liver tissue engineering: Paving the way for tissue-engineered liverQi Wang, Yutian Feng, Anqi Wang, et al.
Nuclear Medicine and Biology|May 7, 2016
Trithiols and their arsenic compounds for potential use in diagnostic and therapeutic radiopharmaceuticalsAnthony J DeGraffenreid, Yutian Feng, Charles L Barnes, et al.
Genome Biology and Evolution|July 13, 2021
The Evolutionary Origins of Extreme Halophilic Archaeal LineagesYutian Feng, Uri Neri, Sean Gosselin, et al.
Pageof 4